Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism

Area of Science:

• Vascular Biology
• Genetics
• Rheumatology

Background:

• Systemic sclerosis (SSc) is characterized by microvascular and macrovascular damage, resembling atherosclerosis.
• Endothelial damage and smooth muscle cell migration are key features of SSc vasculopathy.
• Accelerated macrovascular disease is a significant comorbidity in SSc patients.

Purpose of the Study:

• To investigate the association between angiotensin-converting enzyme (ACE) gene polymorphisms and systemic sclerosis (SSc).
• To explore the potential genetic contribution of ACE I/D polymorphism to SSc development.
• To highlight the current gaps in understanding the renin-angiotensin system's role in SSc pathophysiology.

Main Methods:

• Analysis of ACE gene insertion/deletion (I/D) polymorphism.
• Genotyping for DD, II, and ID genotypes.
• Review of existing literature linking ACE polymorphisms to vascular disorders.

Main Results:

• ACE gene polymorphisms, particularly the D allele, are associated with an increased risk of vascular disorders.
• The ACE D allele frequency in the I/D polymorphism is linked to a higher risk of developing SSc.
• A discrepancy exists between the high prevalence of the ACE D allele and reduced ACE plasma levels in SSc.

Conclusions:

• ACE gene I/D polymorphism may contribute to the genetic predisposition of systemic sclerosis.
• The association of the ACE D allele with SSc suggests a role in vascular injury within the disease.
• Further research is needed to elucidate the regulation and function of the renin-angiotensin system in SSc.